Neovasc Inc. Capital expenditures

Capital expenditures of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capital expenditures growth rates and interactive chart. Capital expenditures, commonly known as Capex, are funds used by a company to acquire, upgrade, and maintain physical or intangible assets such as property, buildings, an industrial plant, technology, software or equipment. Capex is often used to undertake new projects or investments by the firm. A company must invest over its lifetime into productive assets to maintain its competitiveness and ensure its survival.


Highlights and Quick Summary

  • Capital expenditures for the quarter ending December 31, 2021 was $-18 Thousand (a -Infinity% decrease compared to previous quarter)
  • Year-over-year quarterly Capital expenditures decreased by -57.04%
  • Annual Capital expenditures for 2021 was $-164 Thousand (a -51.99% decrease from previous year)
  • Annual Capital expenditures for 2020 was $-342 Thousand (a 40.37% increase from previous year)
  • Annual Capital expenditures for 2019 was $-244 Thousand (a -136.06% decrease from previous year)
  • Twelve month Capital expenditures ending December 31, 2021 was $-164 Thousand (a -24.86% decrease compared to previous quarter)
  • Twelve month trailing Capital expenditures decreased by -52.21% year-over-year
Trailing Capital expenditures for the last four month:
31 Dec '21 30 Sep '21 30 Jun '21 31 Mar '21
$-164 Thousand $-218 Thousand $-442 Thousand $-343 Thousand
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capital expenditures of Neovasc Inc.

Most recent Capital expendituresof NVCN including historical data for past 10 years.

Interactive Chart of Capital expenditures of Neovasc Inc.

Neovasc Inc. Capital expenditures for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $-0.02 $0.0 $-0.1 $-0.04 $-0.16
2020 $-0.07 $-0.22 $-0.01 $-0.04 $-0.34
2019 $-0.08 $-0.06 $-0.06 $-0.04 $-0.24
2018 $-0.03 $-0.12 $0.85 $-0.03 $0.68
2017 $-0.06 $-0.06 $-0.12 $-0.28 $-0.51
2016 $67.63 $-0.02 $-0.23 $-0.31 $67.09
2015 $-0.48 $-0.39 $-0.87 $-0.39 $-2.14
2014 $-0.58 $-0.26 $-0.24 $-0.05 $-1.12
2013 $-0.05 $-0.09 $-0.56 $-0.31 $-1.01
2012 $-0.08 $-0.04 $-0.1 $-0.09 $-0.31
2011 $-0.16 $-0.16

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.